Background {#Sec1}
==========

Intensive stocking in the rapidly developing poultry industry worldwide has become a norm. However, high stocking density causes oxidative stress in broilers \[[@CR1]\] and reduces the tenderness and increases the drip loss of breast muscle \[[@CR2], [@CR3]\]. Oxidation is one of the leading reasons for the deterioration of meat quality \[[@CR4]\], and oxidative stress causes protein and lipid peroxidation as well as cellular damage \[[@CR5], [@CR6]\] which ultimately affects meat quality \[[@CR7]\]. Nicotinamide (NAM) reduces oxidative stress and inhibits reactive oxygen species (ROS) production \[[@CR8], [@CR9]\]. Dietary supplementation with NAM has been observed to minimize the formation of carbonylated proteins in the liver of high-fat fed mice \[[@CR10]\]. Butyrate sodium (BA) could also improve antioxidant capacity in a human study \[[@CR11]\]. Further, the addition of BA can enhance the activities of superoxide dismutase and catalase and reduce the level of malondialdehyde in serum \[[@CR12]\]. Butyrate treatment has been reported to decrease the levels of markers of oxidative stress and apoptosis in mice \[[@CR13]\]. As treatment with NAM and BA both can elevate antioxidant capacity and muscle function, it may improve the muscle quality of broilers under high stocking density. Dietary supplementation with 60 mg/kg niacin (NAM precursor) reduces the drip loss of breast muscles in broilers \[[@CR14]\]. Dietary supplementation with BA can increase broiler weight, decrease abdominal fat percentage \[[@CR15]\], and reduce intramuscular fat content \[[@CR16]\].

Mitochondrial biogenesis has previously been associated with preservation of muscle mass and beneficial effects on metabolism \[[@CR17]\]. Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC1α) is a crucial regulator of mitochondrial biogenesis. Replenishment with nicotinamide adenine dinucleotide (NAD) induces mitochondrial biogenesis by increasing PGC1α expression \[[@CR18], [@CR19]\]. NAM is the primary source of NAD which is obtained through the salvage pathway. As a precursor of NAD, treatment with NAM also enhances PGC-1α expression \[[@CR20]\]. Impaired intramuscular NAD synthesis compromises skeletal muscle mass and strength over time, which can be quickly restored with an oral NAD precursor \[[@CR21]\]. Besides, NAD biosynthesis alleviates muscular dystrophy in a zebrafish model \[[@CR22]\] and promotes muscle function in *Caenorhabditis elegans* \[[@CR23]\]. Addition of niacin (precursor of NAM) has been reported to increase the number of oxidative type I fibres in skeletal muscles of growing pigs \[[@CR24]\] and induce type II to type I muscle fibre transition in sheep \[[@CR25]\]. Further, supplementation with butyrate increases mitochondrial function and biogenesis of skeletal muscle in mice and rats \[[@CR26], [@CR27]\]. Further, the intake of BA increases the percentage of type 1 fibres \[[@CR26], [@CR28]\] and muscle fibre cross-sectional area in skeletal muscle \[[@CR13]\].

Although supplementation with NAM or BA alone can elevate antioxidant capacity and improve the meat quality of broilers, the effect of combined supplementation with NAM and BA on the meat quality of broilers is not clear yet. Therefore, we performed transcriptome sequencing of broiler breast muscles to elucidate the molecular mechanism of the effect of feeding density and nutrient regulation on meat quality.

Results {#Sec2}
=======

Production performance and meat quality {#Sec3}
---------------------------------------

There is no significant difference among the H, L and COMB group in corresponding to FI, BW, BWG and FCR (*P* \> 0.05) (Table [1](#Tab1){ref-type="table"}). Compared with the L group, the H group showed significantly increased cooking loss of breast muscle (*P* \< 0.05). The COMB group showed decreased cooking loss compared with the H group (*P* \< 0.05). Besides, the drip loss in the COMB group was lower than that in the L group, as well (*P* \< 0.05) (Fig. [1](#Fig1){ref-type="fig"}). Table 1Production performance of broilersLHCOMBSEM*P*-valueFI /g28432844284427.81.000BW /g27882745277325.60.802BWG /g16101533156723.60.439FCR1.771.861.820.020.188Production performance included FI (feed intake), BW (body weight), BWG (body weight gain) and FCR (feed conversion ratio)Fig. 1Water holding capacity of breast muscle. Data are shown as the means ± SEM. Different letters a, b indicate that there are significant differences (*P* \< 0.05) among these groups. L, low stocking density (14 birds/m^2^); H, high stocking density (18 birds/m^2^); COMB, combination of NAM and BA (18 birds/m^2^)

The 45-min pH value in the H group was higher than that in the other 2 groups (*P* \< 0.05) while there was no significant difference in 24-h pH values among the groups. Thus, the pH decline during 45 min to 24 h in the H group was significantly higher than that in the other 2 groups, indicating that the H group had rapid pH drop rate, which was attenuated in the COMB group under high stocking density (Fig. [2](#Fig2){ref-type="fig"}). Fig. 2The pH values of breast muscle. Data are shown as the means ± SEM. Different letters a, b indicate that there are significant differences (*P* \< 0.05) among these groups. L, low stocking density (14 birds/m^2^); H, high stocking density (18 birds/m^2^); COMB, combination of NAM and BA (18 birds/m^2^)

Anti-oxidant capacity {#Sec4}
---------------------

The stocking density significantly altered the activity of LDH (*P* = 0.022). The activity of LDH in the H group was higher (*P* \< 0.05) than that in the L group. The COMB group had significantly decreased (*P* \< 0.05) activity of LDH when compared with the H group. However, stocking density had no significant effect on the activities of CK, T-AOC, MDH, anti-superoxide anion and the content of hydroxyproline (Table [2](#Tab2){ref-type="table"}). Table 2Enzyme activities of the breast muscleLHCOMBSEM*P*-valueCK /U/mgprot2.512.412.250.120.702LDH /U/gprot450.38^a^724.10^b^383.22^a^56.740.022T-AOC /U/mgprot100.8182.1786.018.250.650MDH /U/mgprot1.371.211.530.080.252Anti-superoxide anion /U/gprot10.309.3210.390.390.489Hydroxyproline /μg/mg155.56164.22172.018.510.755

RNA sequencing data and differentially expressed genes (DEGs) {#Sec5}
-------------------------------------------------------------

In the principal component analysis (PCA), there was a clear divergence among the H, L and COMB groups. In the Venn diagram, the number of identified genes in the H, L and COMB were 11,777, 12,554 and 11,633, respectively (Fig. [3](#Fig3){ref-type="fig"}). Compared with the H group, the number of DEGs in the L group and COMB group were 3752 and 773, respectively (Fig. [4](#Fig4){ref-type="fig"}). Fig. 3Principal Component Analysis (PCA) and Wayne (VEEN) analysis of gene sets. For the PCA graph, the distance between each sample point represents the distance of the sample. The closer the distance means higher the similarity between samples; for the VEEN graph, the numbers inside the circle represents the sum of the number of expressed genes in the group. The crossover region represents the number of consensus expressed genes for each groupFig. 4Volcanic map of differential expression genes. The abscissa is the fold change of the gene expression difference between the two samples and the ordinate is the statistical test value of the gene expression. Each dot in the figure represents a specific gene, the red dot indicates a significantly up-regulated gene, the green dot indicates a significantly down-regulated gene, and the grey dot is a non-significant differential gene

The gene sets were produced by DEGS. From Venn analysis of genes sets, we found that there were 1310 genes shared in common between the COMB group and the L group. Nevertheless, there were only 6 genes owed by both the COMB group and the H group. Similarly, from the iPath map of metabolic pathways, there were a total of 830 pathways annotated in common. In contrast, there was only 1 pathway owed by both the COMB group and the H group (Fig. [5](#Fig5){ref-type="fig"}). Fig. 5The Veen diagram and the map of Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways analysis of gene sets. For VEEN diagram: the sum of all the numbers inside the circle represents the total gene of the set. The number, circle intersection area represents the number of shared genes among the gene sets. For the map of KEGG metabolic pathway, the red represents the pathway of the common annotation of the genes in the gene sets of two groups. We thank Kanehisa Laboratories for providing the copyright permission of KEGG pathway maps \[[@CR29]\]

Up-regulated genes in the H group {#Sec6}
---------------------------------

Compared with those in the L group, a total of 1894 genes were up-regulated in the H group (Fig. [4](#Fig4){ref-type="fig"}), which were mainly involved in muscle contraction, cell localization, ion transport, lipid metabolism, glycolysis, proteolysis, and immune stress (Fig. [6](#Fig6){ref-type="fig"}). Fig. 6GO enrichment analysis of up-regulated genes in the H group. The abscissa indicates the GO term, and the ordinate indicates the enrichment ratio. "\*"means *P* \< 0.05, "\*\*"means *P* \< 0.01 and "\*\*\*" means *P* \< 0.001

Muscle contraction-related pathways were enriched in the H group. They involved vital genes including MYLK2, NOS1, TMOD4, and Six1 (Table [3](#Tab3){ref-type="table"}). The H group was enriched for cell-localization-related genes such as KEAP1, CDKN1A, ERBB4, and TMOD4 (Table [3](#Tab3){ref-type="table"}). Additionally, high-density up-regulated ion and amino acid transport-related genes included KCNJ12, KCNA7, SLC38A3 and SLC38A4, which are involved in ion transmembrane transport and transporter activity (Table [4](#Tab4){ref-type="table"}). High-density enriched glycolysis-related pathways included fructose metabolism, fructose-2,6-diphosphate 2-phosphatase activity, and fructose 2,6-diphosphate metabolism (Table [5](#Tab5){ref-type="table"}). The lipid metabolism-related genes such as MID1IP1, ACACB and Lpin1 were up-regulated in H group, which are involved in lipid synthesis and lipid oxidation (Table [5](#Tab5){ref-type="table"}). Table 3Muscle contraction and cell location related pathwaysGO IDTerm TypeDescription***P***-valueGenes**Muscle contraction related pathways** GO:0044449CCcontractile fiber part0.026498NOS1; TMOD4 GO:0006936BPmuscle contraction0.000194MYLK2; NOS1 GO:0006941BPstriated muscle contraction0.000908MYLK2; NOS1 GO:0003012BPmuscle system process0.00051MYLK2; NOS1 GO:0051015MFactin filament binding0.002704TMOD4 GO:0003779MFactin binding0.000614TMOD4 GO:0008092MFcytoskeletal protein binding0.033316TMOD4 GO:0004687MFmyosin light chain kinase activity0.022364MYLK2**Cell location related pathways** GO:0051235BPmaintenance of location0.002093KEAP1 GO:0051651BPmaintenance of location in cell0.000837KEAP1 GO:0045185BPmaintenance of protein location0.000645KEAP1 GO:0032507BPmaintenance of protein location in cell0.000486KEAP1 GO:1900180BPregulation of protein localization to nucleus0.032179KEAP1; CDKN1A; ERBB4 GO:2000010BPpositive regulation of protein localization to cell surface0.044234ERBB4 GO:0042306BPregulation of protein import into nucleus0.018345KEAP1; CDKN1A; ERBB4 GO:1904589BPregulation of protein import0.018837KEAP1; CDKN1A; ERBB4Table 4Ion transport related pathwaysGO IDTerm TypeDescription***P-***valueGenes**Ion transport related pathways** GO:0030001BPmetal ion transport0.015075KCNJ12 GO:0002028BPregulation of sodium ion transport0.017458NOS1 GO:0051365BPcellular response to potassium ion starvation0.011244SLC38A3 GO:0006813BPpotassium ion transport0.030866KCNJ12 GO:0034220BPion transmembrane transport0.015681SLC38A4; SLC38A3; KCNJ12 GO:0010107BPpotassium ion import0.004526KCNJ12 GO:0006813BPpotassium ion transport0.030866KCNJ12 GO:0098655BPcation transmembrane transport0.024337SLC38A3; KCNJ12 GO:0006812BPcation transport0.027707SLC38A3; KCNJ12 GO:0098662BPinorganic cation transmembrane transport0.046453KCNJ12 GO:0015075MFion transmembrane transporter activity0.008902KCNA7; SLC38A4; SLC38A3 GO:0046873MFmetal ion transmembrane transporter activity0.007993KCNJ12 GO:0008324MFcation transmembrane transporter activity0.01451SLC38A3; KCNJ12 GO:0022890MFinorganic cation transmembrane transporter activity0.022537KCNJ12 GO:0005261MFcation channel activity0.045897KCNJ12 GO:0005216MFion channel activity0.03925KCNA7; KCNJ12 GO:0015276MFligand-gated ion channel activity0.026498KCNJ12 GO:0015079MFpotassium ion transmembrane transporter activity0.029581KCNJ12Table 5Glycolysis and lipid metabolism related pathwaysGO IDTerm TypeDescription***P-***valueGenes**Glycolysis related pathways** GO:0006000BPfructose metabolic process0.038812PFKFB1 GO:0004331MFfructose-2,6-bisphosphate 2-phosphatase activity0.01682PFKFB1 GO:0003873MF6-phosphofructo-2-kinase activity0.022364PFKFB1 GO:0050308MFsugar-phosphatase activity0.038812PFKFB1 GO:0008443MFphosphofructokinase activity0.038812PFKFB1 GO:0006003BPfructose 2,6-bisphosphate metabolic process0.022364PFKFB1**Lipid metabolism related pathways** GO:0003989MFacetyl-CoA carboxylase activity0.044234ACACB GO:0019217BPregulation of fatty acid metabolic process0.016548MID1IP1; ACACB GO:0046949BPfatty-acyl-CoA biosynthetic process0.03336ACACB GO:0019432BPtriglyceride biosynthetic process0.03336Lpin1 GO:0046463BPacylglycerol biosynthetic process0.038812Lpin1 GO:0046460BPneutral lipid biosynthetic process0.038812Lpin1 GO:0046322BPnegative regulation of fatty acid oxidation0.01682ACACB GO:0031998BPregulation of fatty acid beta-oxidation0.044234ACACB GO:0031999BPnegative regulation of fatty acid beta-oxidation0.011244ACACB GO:0045723BPpositive regulation of fatty acid biosynthetic process0.027877MID1IP1 GO:0010884BPpositive regulation of lipid storage0.044234ACACB GO:2001295BPmalonyl-CoA biosynthetic process0.011244ACACB GO:2001293BPmalonyl-CoA metabolic process0.01682ACACB GO:0010565BPregulation of cellular ketone metabolic process0.047727MID1IP1; ACACB

Stress response pathways including non-biologically stimulated cellular responses, extracellular stimuli response and nutritional level response were also enriched in the H group. Furthermore, high-density up-regulated proteolysis-related genes include TINAG, USP24, OTUD1, KEAP1, KLHL34, and SMCR8. Also, high-density enriched immune pathways include the regulation of host defence responses to viruses and prostaglandin receptor-like binding (Table [6](#Tab6){ref-type="table"}). Table 6Proteolysis, immune and stress related pathwaysGO IDTerm TypeDescription***P-***valueGenes**Proteolysis related pathways** GO:0008234MFcysteine-type peptidase activity0.032179TINAG; USP24; OTUD1 GO:0031463CCCul3-RING ubiquitin ligase complex0.028791KEAP1; KLHL34 GO:0010499BPproteasomal ubiquitin-independent protein catabolic process0.03336KEAP1 GO:0010508BPpositive regulation of autophagy0.034688SMCR8 GO:1902902BPnegative regulation of autophagosome assembly0.03336SMCR8 GO:1901096BPregulation of autophagosome maturation0.011244SMCR8 GO:1901098BPpositive regulation of autophagosome maturation0.011244SMCR8**Immune and stress related pathways** GO:0031867MFEP4 subtype prostaglandin E2 receptor binding0.005638FEM1A GO:0031862MFprostanoid receptor binding0.005638FEM1A GO:0050691BPregulation of defense response to virus by host0.031097ALKBH5; ALPK1 GO:0002230BPpositive regulation of defense response to virus by host0.026558ALKBH5; ALPK1 GO:0071214BPcellular response to abiotic stimulus0.042948CDKN1A; SLC38A3 GO:0009991BPresponse to extracellular stimulus0.022488ACACB; CDKN1A; SLC38A3 GO:0031667BPresponse to nutrient levels0.018345ACACB; CDKN1A; SLC38A3

In Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis, genes involved in calcium signalling pathway (RYR), inflammatory mediator regulation of RTP channels (PLA2) and chemokine signalling pathway (SOS) (Fig. S[1](#MOESM1){ref-type="media"}, S[2](#MOESM2){ref-type="media"} and S[3](#MOESM3){ref-type="media"}) were enriched in the H group.

Down-regulated genes in the H group {#Sec7}
-----------------------------------

Compared with those in the L group, a total of 1858 genes were down-regulated in the H group (Fig. [4](#Fig4){ref-type="fig"}), which were involved in cell adhesion, cell matrix, and cell migration, etc. (Fig. [7](#Fig7){ref-type="fig"}). Fig. 7GO enrichment analysis of down-regulated genes in the H group. The abscissa indicates the GO term, and the ordinate indicates the enrichment ratio. "\*"means *P* \< 0.05, "\*\*"means *P* \< 0.01 and "\*\*\*" means *P* \< 0.001

The genes involved in muscle development include muscle fibre assembly and binding (LMOD2, MYOZ2 and ACTN1, etc.) and muscle fibre development (DSG2, LMOD2 and FSCN1, etc.), which were down-regulated in H group (Table [7](#Tab7){ref-type="table"}). High-density also down-regulated genes related to cell-matrix pathways such as MMP9, FBLN1, THBS4, and VCAN. High-density also down-regulated collagen synthesis and collagen binding related genes including ADAMTS3, ADAMTS14, COL1A2, and LUM (Table [8](#Tab8){ref-type="table"}). Besides, the adhesion-associated genes including DSG2, CSTA, THY1, TGFBI, NOV, CDH11 and FN1 were diminished. Additionally, antioxidant genes including MGST2, PTGS2, NCF1, SOD3, and CYBB were also down-regulated (Table [9](#Tab9){ref-type="table"}). Table 7Muscle development related pathwayGO IDTerm TypeDescription***P-***valueGenes**Muscle development related pathways** GO:0030239BPmyofibril assembly0.021003LMOD2; MYOZ2 GO:0043205CCfibril0.008763FN1; LTBP1 GO:0045214BPsarcomere organization0.045011LMOD2; ACTN1 GO:0051017BPactin filament bundle assembly9.31E-05LIMA1; ACTN1; DPYSL3; FSCN1 GO:0061572BPactin filament bundle organization0.00013LIMA1; ACTN1; DPYSL3; FSCN1 GO:0007015BPactin filament organization0.001785LIMA1; LMOD2; ACTN1; DPYSL3; FSCN1 GO:0030036BPactin cytoskeleton organization0.002238LMOD2; MYOZ2; Fgf7; ACTN1; MYL6; CNN2; DOCK2; FSCN1 GO:0031032BPactomyosin structure organization0.001641LMOD2; MYOZ2; ACTN1; MYL6; CNN2 GO:0003779MFactin binding0.000306MYH15; LIMA1; LMOD2; MYOZ2; ACTN1; MYL6; CNN2; MYL3; FSCN1 GO:0005523MFtropomyosin binding0.006889LMOD2; S100A6 GO:0070051MFfibrinogen binding0.016237FBLN1 GO:0050436MFmicrofibril binding0.032211LTBP1 GO:0060537BPmuscle tissue development0.029507DSG2; EYA2; BMP5; ITGA8 GO:0032970BPregulation of actin filament-based process0.033864DSG2; LIMA1; LMOD2; WNT11; SERPINF2; FSCN1; F2RL1 GO:0030029BPactin filament-based process0.003744LMOD2; MYOZ2; Fgf7; ACTN1; MYL6; CNN2; DOCK2; FSCN1 GO:0014883BPtransition between fast and slow fiber0.047928TNNI1 GO:1902724BPpositive regulation of skeletal muscle satellite cell proliferation0.047928HGFTable 8Cellular matrix and collagen related pathwayGO IDTerm TypeDescription***P-***valueGenes**Cellular matrix related pathways** GO:0030198BPextracellular matrix organization1.05E-06MMP9; TGFBI; ABI3BP; POSTN; FBLN1, etc GO:0044420CCextracellular matrix component2.83E-05COL1A2; FN1; THBS2; THBS4; LTBP1, etc GO:0005578CCproteinaceous extracellular matrix1.71E-11FN1; THBS2; ADAMTS3; ADAMTS14; COL12A1, etc GO:0005614CCinterstitial matrix0.013106FN1; ABI3BP GO:0043062BPextracellular structure organization1.15E-06MMP9; TGFBI; ABI3BP; ADAMTS14; POSTN, etc GO:0005201MFextracellular matrix structural constituent0.017449MGP; VCAN; FBLN1 GO:0031232CCextrinsic component of external side of plasma membrane0.032211SERPINE2 GO:0019897CCextrinsic component of plasma membrane0.000874SERPINE2; S100A6; RGS1; KCNAB1 GO:1990430MFextracellular matrix protein binding0.047928ITGB8**Collagen related pathways** GO:0032964BPcollagen biosynthetic process0.047928ADAMTS3 GO:0032963BPcollagen metabolic process0.027114MMP9; ADAMTS3 GO:0010712BPregulation of collagen metabolic process0.023978SERPINF2; FAP GO:0010710BPregulation of collagen catabolic process0.032211FAP GO:0030199BPcollagen fibril organization0.000216ADAMTS14; SFRP2; LUM; SERPINF2 GO:0005518MFcollagen binding0.00265TGFBI; ABI3BP; COMP; LUM GO:0005540MFhyaluronic acid binding0.037432TNFAIP6; VCAN GO:0005581CCcollagen trimer0.000699COL1A2; COL12A1; COLEC12; LUM; COL14A1 GO:0005583CCfibrillar collagen trimer0.001541COL1A2; LUM GO:0005539MFglycosaminoglycan binding3.59E-09MDK; SLIT3; NOV; SERPINE2; JCHAIN, etc GO:1901617BPorganic hydroxy compound biosynthetic process0.033592NR4A2; PLTP; LCAT; AKR1D1Table 9Cell adhesion and antioxidant related pathwayGO IDTerm TypeDescription***P-***valueGenes**Cell adhesion related pathways** GO:0007155BPcell adhesion3.1E-08DSG2; TGFBI; NOV; FN1; THBS2; COMP, etc GO:0098609BPcell-cell adhesion0.030671DSG2; CSTA; NOV; CDH11; THBS4; BMP5, etc GO:0007160BPcell-matrix adhesion0.02187FN1; ITGB8; ITGA8 GO:0050839MFcell adhesion molecule binding0.000141DSG2; THY1; TGFBI; NOV; FN1; THBS4, etc GO:0005911CCcell-cell junction0.001091DSG2; CD3E; GJA1; NOV; ABCB11; ACTN1, etc GO:0007045BPcell-substrate adherens junction assembly0.010838THY1; FN1 GO:0045216BPcell-cell junction organization2.94E-06DSG2; THY1; GJA1; FN1; WNT11; FSCN1 GO:0007043BPcell-cell junction assembly0.028627WNT11; FSCN1 GO:0034332BPadherens junction organization0.048995THY1; FN1 GO:0034329BPcell junction assembly0.002273THY1; FN1; WNT11; FSCN1 GO:0010811BPpositive regulation of cell-substrate adhesion0.00285THY1; FN1; ABI3BP; EDIL3; FBLN1 GO:0034333BPadherens junction assembly0.027114THY1; FN1 GO:0005178MFintegrin binding2.56E-07THY1; TGFBI; NOV; FN1; THBS4; EDIL3, etc**Antioxidant related pathways** GO:0016209MFantioxidant activity0.040595MGST2; PTGS2; SOD3 GO:0004784MFsuperoxide dismutase activity0.047928SOD3 GO:0006801BPsuperoxide metabolic process0.00047NCF1; SOD3; CYBB GO:1901031BPregulation of response to reactive oxygen species0.048995HGF GO:0050664MFoxidoreductase activity, acting on NAD(P) H, oxygen as acceptor0.01556NCF1; CYBB GO:0098869BPcellular oxidant detoxification0.040595MGST2; PTGS2; SOD3

In KEGG enrichment analysis, down-regulated genes in the H group were involved in ECM-receptor interaction (COL1A, THBS1, FN1, TN, ITGA5, ITGA8 and ITGB8), adherens junction (SHP-1, TGFβR, α-Actinin and Slug) and focal adhesion (Actinin and MLC) (Fig. S[4](#MOESM4){ref-type="media"}, S[5](#MOESM5){ref-type="media"} and S[6](#MOESM6){ref-type="media"}).

Up-regulated genes in the COMB group {#Sec8}
------------------------------------

Compared with those in the H group, up-regulated genes in the COMB group were involved in muscle development, hyaluronic acid synthesis, mitochondrial function, and redox pathway (Fig. [8](#Fig8){ref-type="fig"}). Fig. 8GO enrichment analysis of up-regulated genes in the COMB group. The abscissa indicates the GO term, and the ordinate indicates the enrichment ratio. "\*"means *P* \< 0.05, "\*\*"means *P* \< 0.01 and "\*\*\*" means *P* \< 0.001

The muscle development-related pathways enriched in the COMB group included positive regulation of muscle tissue development and muscle cell decision processes, which involved key genes such as MYF6, LMCD1 and TRPC3. Besides, the COMB group was enriched for mitochondria-associated pathways such as electron transport chains, mitochondrial respiratory chain complex I and mitochondrial protein complex pathways, which involved genes including TOMM6, NDUFV1, NDUFS5, NDUFB2, NDUFA2, LMCD1, ZNF593 and COASY (Table [10](#Tab10){ref-type="table"}). The hyaluronic acid-related genes up-regulated in the COMB group included HYAL1 and HYAL3. Besides, the redox-related genes including LDHD, CPOX, SUOX, NDUFV1, GRHPR, DOHH and NDUFA2 were up-regulated in the COMB group, which were involved in the pathways such as redox process, NAD binding, NADPH binding and NADH dehydrogenase complex (Table [11](#Tab11){ref-type="table"}). In KEGG enrichment analysis, up-regulated genes in the COMB group were involved in oxidative phosphorylation (NDUFS5, NDUFV1, NDUFA2, NDUFA13, NDUFB2, NDUFB7 and NDUFC2) (Fig. S[7](#MOESM7){ref-type="media"}). Table 10Muscle development and mitochondria related pathwayNumberGO IDTerm TypeDescription***P-***valueGenes**Muscle development related pathways** GO:1901741BPpositive regulation of myoblast fusion0.000717MYF6 GO:0010831BPpositive regulation of myotube differentiation0.003478MYF6 GO:0014743BPregulation of muscle hypertrophy0.00447LMCD1; TRPC3 GO:0048643BPpositive regulation of skeletal muscle tissue development0.00447MYF6 GO:1901863BPpositive regulation of muscle tissue development0.020276MYF6 GO:0051149BPpositive regulation of muscle cell differentiation0.025719MYF6 GO:0048743BPpositive regulation of skeletal muscle fiber development0.035113MYF6 GO:0045844BPpositive regulation of striated muscle tissue development0.017276MYF6 GO:0051155BPpositive regulation of striated muscle cell differentiation0.011102MYF6 GO:0048636BPpositive regulation of muscle organ development0.017276MYF6 GO:0014744BPpositive regulation of muscle adaptation0.023546TRPC3**Mitochondria related pathways** GO:0042775BPmitochondrial ATP synthesis coupled electron transport0.023546NDUFV1 GO:0022904BPrespiratory electron transport chain0.025719NDUFV1 GO:0022900BPelectron transport chain0.029237NDUFV1 GO:0098803CCrespiratory chain complex0.002546NDUFV1; NDUFS5; NDUFB2 GO:0045271CCrespiratory chain complex I0.000532NDUFV1; NDUFS5; NDUFB2 GO:0005747CCmitochondrial respiratory chain complex I0.000532NDUFV1; NDUFS5; NDUFB2 GO:0098798CCmitochondrial protein complex0.002727TOMM6; NDUFV1; NDUFS5; NDUFB2 GO:0098800CCinner mitochondrial membrane protein complex0.009305NDUFV1; NDUFS5; NDUFB2 GO:0005742CCmitochondrial outer membrane translocase complex0.046544TOMM6 GO:0098779BPmitophagy in response to mitochondrial depolarization0.04939LMCD1; ZNF593Table 11Hyaluronan and redox related pathwayNumberGO IDTerm TypeDescription***P-***valueGenes**Hyaluronan related pathways** GO:0030213BPhyaluronan biosynthetic process0.023546HYAL1 GO:0030214BPhyaluronan catabolic process0.000207HYAL3; HYAL1 GO:0030212BPhyaluronan metabolic process0.001519HYAL3; HYAL1 GO:1900106BPpositive regulation of hyaluranon cable assembly0.017711HYAL1 GO:0004415MFhyalurononglucosaminidase activity0.000514HYAL3; HYAL1 GO:0033906MFhyaluronoglucuronidase activity0.011842HYAL3 GO:0036117CChyaluranon cable0.011842HYAL1 GO:0050501MFhyaluronan synthase activity0.017711HYAL1 GO:0006027BPglycosaminoglycan catabolic process0.00122HYAL3; HYAL1 GO:0030203BPglycosaminoglycan metabolic process0.039481HYAL3; HYAL1 GO:0006026BPaminoglycan catabolic process0.003025HYAL3; HYAL1 GO:1903510BPmucopolysaccharide metabolic process0.013602HYAL3; HYAL1**Redox related pathways** GO:0055114BPoxidation-reduction process0.028445LDHD; CPOX; SUOX; NDUFV1; GRHPR; DOHH; NDUFA2 GO:1990204CCoxidoreductase complex0.006475NDUFV1; NDUFS5; NDUFB2 GO:0016491MFoxidoreductase activity0.045293LDHD; CPOX; SUOX; NDUFV1; GRHPR; DOHH GO:0016651MFoxidoreductase activity, acting on NAD(P)H0.045042NDUFV1 GO:0051287MFNAD binding0.031684NDUFV1; GRHPR GO:0070402MFNADPH binding0.040845GRHPR GO:0030964CCNADH dehydrogenase complex0.000532NDUFV1; NDUFS5; NDUFB2

Down-regulated genes in the COMB group {#Sec9}
--------------------------------------

Compared with those in the H group, down-regulated genes in the COMB group were involved in the inflammatory response, acid metabolism, fatty acid metabolism, and glycolysis-related pathways (Fig. [9](#Fig9){ref-type="fig"}). Fig. 9GO enrichment analysis of down-regulated genes in the COMB group. The abscissa indicates the GO term, and the ordinate indicates the enrichment ratio. "\*"means *P* \< 0.05, "\*\*"means *P* \< 0.01 and "\*\*\*" means *P* \< 0.001

The inflammatory response-related genes down-regulated in the COMB group included CCR5 and ALOX5 while the immune response-related genes included C1S, BLK, CCR5 and MARCH1 (Table [12](#Tab12){ref-type="table"}). The acid metabolism-related pathways include organic acid synthesis process, oxoacid metabolism process and carboxylic acid synthesis process, which involved genes such as PSAT1, SCD, MAT1A, ALOX5, ST3GAL1 and ALDOB. The genes involved in fatty acid metabolism pathways include SCD and ALOX5. In addition, down-regulated genes in the COMB group were involved in glycolytic and carbohydrate metabolism, which included GALNT16, ST3GAL1, ALDOB and MAT1A (Table [13](#Tab13){ref-type="table"}). Table 12Immune response and inflammatory response related pathwaysNumberGO IDTerm TypeDescription***P-***valueGenes**Immune response and inflammatory response related pathways** GO:0006954BPinflammatory response0.004612CCR5; ALOX5 GO:0002532BPproduction of molecular mediator involved in inflammatory response0.01346ALOX5 GO:0002538BParachidonic acid metabolite production involved in inflammatory response0.008097ALOX5 GO:0002540BPleukotriene production involved in inflammatory response0.008097ALOX5 GO:0002253BPactivation of immune response0.005145C1S; BLK GO:0050778BPpositive regulation of immune response0.017271C1S; BLK GO:0045087BPinnate immune response0.005036C1S; BLK GO:0006956BPcomplement activation0.000944C1S GO:0001867BPcomplement activation, lectin pathway7.08E-05C1S GO:0006958BPcomplement activation, classical pathway0.000197C1S GO:0004950MFchemokine receptor activity0.047636CCR5 GO:0016493MFC-C chemokine receptor activity0.024101CCR5 GO:0090026BPpositive regulation of monocyte chemotaxis0.024101CCR5 GO:0002495BPantigen processing and presentation of peptide antigen via MHC class II0.032008MARCH1 GO:0042287MFMHC protein binding0.045049MARCH1Table 13Organic acid, faty acid metabolic process, glycolytic and carbohydrate metabolism related pathwaysNumberGO IDTerm TypeDescription***P-***valueGenes**Organic acid and faty acid metabolic process related pathways** GO:0006082BPorganic acid metabolic process0.002344PSAT1; SCD; MAT1A; ALOX5; ST3GAL1; ALDOB GO:0016053BPorganic acid biosynthetic process0.006961PSAT1; SCD; ALOX5 GO:0043436BPoxoacid metabolic process0.002254PSAT1; SCD; MAT1A; ALOX5; ST3GAL1; ALDOB GO:0046394BPcarboxylic acid biosynthetic process0.006961PSAT1; SCD; ALOX5 GO:0019752BPcarboxylic acid metabolic process0.001555PSAT1; SCD; MAT1A; ALOX5; ST3GAL1; ALDOB GO:0006633BPfatty acid biosynthetic process0.012538SCD; ALOX5 GO:0006636BPunsaturated fatty acid biosynthetic process0.002054SCD; ALOX5 GO:0016215MFacyl-CoA desaturase activity0.002706SCD**Glycolytic and carbohydrate metabolism related pathways** GO:0030388BPfructose 1,6-bisphosphate metabolic process0.01613ALDOB GO:0006000BPfructose metabolic process0.018794ALDOB GO:0070061MFfructose binding0.010782ALDOB GO:0061609MFfructose-1-phosphate aldolase activity0.002706ALDOB GO:0004332MFfructose-bisphosphate aldolase activity0.010782ALDOB GO:0005975BPcarbohydrate metabolic process0.029095GALNT16; ST3GAL1; ALDOB GO:0030246MFcarbohydrate binding0.041651GALNT16; ALDOB

In KEGG enrichment analysis, genes involved in the regulation of lipolysis in adipocytes (PLIN), glycolysis/gluconeogenesis (ALDO) and arachidonic acid metabolism (ALOX5) were down-regulated in the COMB group (Fig. S[8](#MOESM8){ref-type="media"}, S[9](#MOESM9){ref-type="media"} and S[10](#MOESM10){ref-type="media"}).

Transcriptome differential gene verification {#Sec10}
--------------------------------------------

The transcriptome differential genes were verified by real-time PCR, and the gene expression pattern was consistent with the transcriptome results (Fig. [10](#Fig10){ref-type="fig"}). Fig. 10The mRNA relative expression of DEGs quantified by quantitative reverse transcription-PCR. Data presented as means ± SEM

Discussion {#Sec11}
==========

In the current study, the H group showed significantly increased cooking loss of breast muscle when compared with the L group. The muscle disease such as PSE (Pale, Soft and Exudative) meat \[[@CR30]\] and wooden breast \[[@CR31]\] have higher cooking loss than normal meat.

Stress is an essential cause of the decline in meat quality. In this study, the activity of LDH in the H group was higher than that in the L group. In transcriptome analysis, the enriched genes in the H group were involved in stimuli response pathway. In the H group, genes encoding nitric oxide synthase 1 (NOS1), Kelch-Like ECH-associated protein 1 (KEAP1) and cyclin-dependent kinase inhibitor 1A (p21, Cip1) (CDKN1A) were up-regulated. High levels of NO reduce the antioxidant capacity of post-mortem muscles, increasing the accumulation of ROS and reactive nitrogen, resulting in high levels of protein oxidation. Studies have shown that inhibition of nitric oxide synthase can significantly reduce protein carbonyl content and protein oxidation \[[@CR32]\]. Inhibition of CDKN1A expression by miRNAs promotes myoblast proliferation \[[@CR33]\]. Up-regulation of KEAP1 expression increases the degradation of Nrf2 in cells, making cells more susceptible to free radical damage \[[@CR34]\]. Heat stress can reduce the oxidative stability of broiler muscle protein and reduce the strength of the myofibrillar gel, resulting in increased drip loss and cooking loss in broilers \[[@CR35]\]. A study has shown that genes involved in the stimulation response pathway are significantly enriched in muscles with high drip loss \[[@CR36]\]. Therefore, increased expression of stress pathway-related genes such as KEAP1 and CDKN1A may be one of the causes of muscle quality deterioration.

This study found that the H group had the fastest pH decline rate. The rapid decline in pH is usually accompanied by an increase in the rate of glycolysis and the accumulation of lactic acid, resulting in a decrease of muscle function \[[@CR37]\]. In this study, high stocking density led to up-regulation of genes involved in glycolysis and fat metabolism pathways. Anaerobic glycolysis is a vital energy metabolism pathway for post-mortem broilers. Under anaerobic conditions, muscle glycogen degradation occurs through glycolysis, which causes pyruvate to synthesize lactic acid, thus leading to a decrease in muscle pH due to the accumulation of lactic acid \[[@CR38], [@CR39]\]. High stocking density in this study also caused up-regulation of striated muscle contraction pathway-related genes such as SIX homeobox 1 (Six1). It has been found that white streak muscles have up-regulated expression of striated muscle contraction-related genes compared with normal meat \[[@CR40]\]. Six1 converts slow muscle fibres into fast muscle fibres \[[@CR41], [@CR42]\]. The proportion of fast muscle fibres was negatively correlated with post-mortem pH \[[@CR43]\]. Besides, the enriched genes in the H group were involved in calcium transport, sodium transport, and cation transport. Importantly, ion balance is the basis for maintaining normal physiological functions. Abnormal metabolism caused by high concentrations of calcium ions may be associated with the incidence of turkey PSE \[[@CR44]\]. Furthermore, changes in muscle cation homeostasis may mark the beginning of muscle degeneration \[[@CR45]\] and cause a reduction in meat quality \[[@CR46]\].

Dietary supplementation with niacin (nicotinamide precursor) at 60 mg/kg was reported to reduce the drip loss of breast muscles in broilers \[[@CR14]\]. In our study, the COMB group showed significantly reduced drip loss and cooking loss compared with the H group. Further, the COMB group showed significantly decreased activity of LDH compared to the H group. Besides, the COMB group showed inhibited expression of glycolytic and inflammation genes \[[@CR37]\].

In KEGG enrichment analysis, the enriched genes in the H group were involved in inflammatory mediator regulation of RTP channels and chemokine signalling pathway. In contrast, the up-regulated genes in the COMB group were involved in the inflammatory response. Macrophage infiltration in the pectoral muscle might cause muscle damage \[[@CR47]\]. The muscle disease such as white striped muscle is usually accompanied by elevated expression of immune-related genes \[[@CR40]\]. During tissue degeneration, immune cells immediately enter the site of injury, triggering an inflammatory response, and attracting more immune cells to the damaged area. It can cause phagocytosis of cell debris and release of cytokines, prostaglandins and other signalling proteins, resulting in interstitial spaces \[[@CR48]\].

We found that key genes down-regulated in the H group, such as MYOZ2, were involved in muscle development, cell adhesion, cell matrix, collagen, and cytoskeleton. MYOZ2 belongs to sarcomeric family and links calcineurin to alpha-actinin at the Z-line of skeletal muscle sarcomere and can play a role in skeletal muscle differentiation and growth \[[@CR49]\]. It was suggested that MYOZ2 knockout mice had neuromuscular disease \[[@CR50]\]. Also, genes down-regulated in the H group were involved in cell matrix and collagen pathways. Extracellular matrix (ECM) is a major macromolecule in skeletal muscle and has a substantial effect on meat quality. The remodelling of ECM is mainly regulated by matrix metalloproteinases. The expression of matrix metalloproteinase-1 is negatively correlated with cooking loss and positively correlated with hydraulic performance \[[@CR51]\]. Collagen is an abundant connective tissue protein that is an important factor in the tenderness and texture of the meat and is well resistant to physical damage during cooking \[[@CR52]\]. The addition of collagen increases the ability of pork \[[@CR53]\] and poultry \[[@CR54]\] to combine with water and reduces cooking losses. Furthermore, high stocking density downregulates cell adhesion, cytoskeletal and integrin binding-related genes such as integrin subunit alpha 8 (ITGA8), integrin subunit beta 8 (ITGB8) and integrin subunit beta like 1 (ITGBL1). Proteolytic degradation of cell adhesion proteins is associated with the production of drip channels \[[@CR55]\]. The cytoskeleton is a highly complex network composed of a large number of connections between myofibrils and myofibrillar membranes. Degradation of the cytoskeleton causes extracellular water to flow into the muscle cells, thereby increasing drip loss \[[@CR56]\]. Integrins are heterodimeric cell adhesion molecules that bind the extracellular matrix to the cytoskeleton and play an essential role in controlling cell membrane-cytoskeletal attachment and signalling pathways \[[@CR57]\]. The β-chain integrin is responsible for the attachment of the cell membrane to the cytoskeleton \[[@CR58]\]. Degradation of β1 integrin promotes the formation of water channels between cells and cell membranes, thereby increasing drip loss \[[@CR59]\]. In addition, it has been found that integrins are inversely related to pork drip loss \[[@CR60]\].

Compared with the H group, the COMB group showed up-regulation of muscle development, hyaluronic acid levels, mitochondrial function, and the redox pathway. Studies have found that hyaluronic acid is a crucial water-holding molecule \[[@CR61], [@CR62]\]. Furthermore, supplementation with antioxidant isoflavones can be achieved by reducing lipid peroxidation and increasing oxidative stability in the pectoral muscles \[[@CR63]\]. Therefore, enhanced hyaluronic acid biosynthesis and antioxidant capacity may improve muscle quality.

Additionally, up-regulated genes in the COMB group involved the complex I-related gene NDUFS5. The mitochondrial respiratory chain (MRC) consists of four membrane-bound electron transport protein complexes (I-IV) and ATP synthase (complex V) that produce ATP for cellular processes. Complex I deficiency, NADH ubiquinone oxidoreductase is the most common form of MRC dysfunction and is associated with a variety of diseases \[[@CR64], [@CR65]\]. Complex I deficiency leads to various physiological disorders such as ATP depletion, calcium homeostasis, ROS accumulation \[[@CR66]\] and induction of apoptosis \[[@CR67]\]. A study found that mitochondrial and oxidative phosphorylation-related gene expression was negatively correlated with drip loss. A negative correlation with drip loss means that there is a decrease in the number of mitochondria in muscles with high drip loss \[[@CR68]\].

Conclusion {#Sec12}
==========

High stocking density may cause oxidative stress, abnormal muscle contraction, and abnormal metabolism of glycolipids; destroy ion channels and cell matrix; reduce muscle strength by inhibiting muscle development, and cell adhesion and collagen synthesis, all of which result in reduced muscle function. Supplementation with NAM and BA in combination can improve mitochondrial function and antioxidant capacity, and inhibit inflammatory response and glycolysis by promoting muscle development and hyaluronic acid synthesis, thereby reducing drip loss of the breast muscle and improving muscle quality (Fig. [11](#Fig11){ref-type="fig"}). Fig. 11The graphic description of the normalization effect of nicotinamide and sodium butyrate on breast muscle. This is the original graph drafted by the authors of this article

Methods {#Sec13}
=======

Experimental birds, diets, and management {#Sec14}
-----------------------------------------

Amount of 300 Cobb broilers (21-day-old) were divided into 3 groups: low stocking density (L, 14 birds/m^2^), high stocking density (H, 18 birds/m^2^) and combination of NAM and BA (COMB, 18 birds/m^2^), with 6 replicates for each group. The stocking densities of this study are referred to Vargas-Galicia et al. \[[@CR69]\]. The L and H groups were fed a basal diet. The COMB group was fed basal diet supplemented with 50 mg/kg NAM and 500 mg/kg BA. The dosage 50 mg/kg NAM and 500 mg/kg BA used in this study were based on our previous studies \[[@CR70], [@CR71]\]. Experimental diets were designed to meet nutrient requirements of National Research Council (1994) \[[@CR72]\]. The nutrient levels and composition of basic diet were shown in Table [14](#Tab14){ref-type="table"}. Broilers in this study were raised from 21-day-old to 42-day-old, and feed and water were provided ad libitum. Table 14The composition and nutrient level of basal dietIngredientPercentNutrientsPercentCorn62.05Metabolic energy3100 KcalSoybean meal26.90Crude Protein18.98Corn Gluten Meal4.00Lysine1.04Soybean oil3.10Methionine0.49DL-Methionine0.18Threonine0.74L-Lysine sulphate0.40Tryptophan0.24Sodium chloride0.30Calcium0.86Choline chloride (50%)0.15Available Phosphorus0.32Vitamin premix^b^0.02Met+Cys^c^0.80Trace mineral premix^a^0.20Dicalcium phosphate1.40Limestone1.20Phytase0.02Antioxidant0.03Medical stone0.05^a^ The trace mineral premix provided the following per kg of diets: Cu, 16 mg (as CuSO~4~·5H~2~O); Zn, 110 mg (as ZnSO~4~); Fe, 80 mg (as FeSO~4~·H~2~O); Mn, 120 mg (as MnO); Se, 0.3 mg (as Na~2~SeO~3~); I, 1.5 mg (as KI); Co, 0.5 mg^b^ The vitamin premix provided the following per kg of diets: vitamin A, 10,000 IU; vitamin D3, 2400 IU; vitamin E, 20 mg; vitamin K3, 2 mg; vitamin B1, 2 mg; vitamin B2, 6.4 mg; VB6, 3 mg; VB12, 0.02 mg; biotin, 0.1 mg; folic acid, 1 mg; pantothenic acid, 10 mg; nicotinamide, 30 mg^c^ Met+Cys: Methionine+ Cysteine

Production performance determination and sample collection {#Sec15}
----------------------------------------------------------

On 42-day, remove feed for 5 h and record the remaining feed per cage, then weight the body weight (BW) of broilers. Calculate body weight gain (BWG), feed intake (FI) and the feed conversion rate (FCR).

For breast collection, one broiler per replicate was randomly selected and euthanized by intravenous injection of pentobarbital sodium (390 mg/ml) at a dose of 300 mg/kg. The breast muscle was collected for meat quality analysis and further study.

Each group had six replicates for the determination of meat quality, enzyme activities and mRNA relative expression; there were three biology replicates in each group for RNA-sequencing.

Meat quality analysis {#Sec16}
---------------------

The meat quality of right side major pectoral muscle was quickly determined after slaughtering. The drip loss was determined according to Liu et al. \[[@CR73]\]. Cooking loss was measured according to the protocol described by Cai et al. \[[@CR74]\]. The pH values of the pectoral muscle at 45 min and 24 h were measured by a pH meter (testo 205; Germany). Each sample was tested at 3 different locations (top, middle and bottom) and the average of 3 measurements was calculated.

Enzyme activity determination in breast muscle {#Sec17}
----------------------------------------------

The total antioxidant capacity (T-AOC, cat\#A015), anti-superoxide anion (cat\#A052), the activities of creatine kinase (CK, cat\#A032), lactate dehydrogenase (LDH, cat\#A020--2), malic dehydrogenase (MDH, cat\#A021--2), and the content of hydroxyproline (cat\# A030--2) in breast muscle were measured by commercial analytical kits (Jian Cheng Bioengineering Institute, Nanjing, China).

RNA extraction, library preparation and Illumina Hiseq X ten sequencing {#Sec18}
-----------------------------------------------------------------------

Total RNA from the breast muscle was extracted by TRIzol® Reagent (Invitrogen, Carlsbad, CA, USA). The RNA quality was then measured by 2100 Bioanalyser (Agilent Technologies, Santa Clara, CA, USA) and quantified using the ND-2000 (Nanodrop Technologies, Wilmington, Delaware).

RNA-seq library was constructed according to TruSeqTM RNA sample preparation Kit from Illumina (San Diego, CA, USA), then was sequenced with the Illumina HiSeq X Ten (2 × 150 bp read length).

Read mapping, differential expression analysis and functional enrichment {#Sec19}
------------------------------------------------------------------------

SeqPrep and Sickle were applied to process raw paired-end reads. Then use TopHat version2.0.0 \[[@CR75]\] software to align the clean reads to the reference genome.

FRKM method was applied to identify differentially expressed genes (DEGs). RSEM \[[@CR76]\] was used to quantify gene abundances. Differential gene expression was analyzed by R statistical package software EdgeR \[[@CR77]\]. Goatools and KOBAS \[[@CR78]\] were applied for KEGG pathway enrichment and GO functional analysis.

The mRNA expression of muscle developmental genes {#Sec20}
-------------------------------------------------

Several differentially expressed genes involved muscle development were validated by real-time PCR analysis. The mRNA expression of muscle was determined as we previously described \[[@CR71]\]. The primer sequences of target gene and housekeeping gene beta-actin were shown in Table [15](#Tab15){ref-type="table"}. The results of gene expression were analyzed and compared using 2^-ΔΔCT^. Table 15Real time PCR primer sequenceGenePrimer sequence (5′-3′)SizeAccession NO.*GAPDH*Forward: GGTAGTGAAGGCTGCTGCTGATG200NM_204305.1Reverse: AGTCCACAACACGGTTGCTGTATC*ERBB4*Forward: ATCACCAGCATCGAGCACAACAG114NM_001030365.1Reverse: CAGGTTCTCCAGTGGCAGGTATTC*TMOD4*Forward: GATGGAGATGGCGACGATGCTG135NM_204774.1Reverse: TTCTTCTGCTTGCGACGGAGTTC*PTGS2*Forward: ACTGCTGGCCGCTCTCCTTG121NM_001167719.1Reverse: CCTCGTGCAGTCACATTCATACCG*COL1A2*Forward: TCCTCCTGGTAACAACGGTCCTG85NM_001079714.2Reverse: GAGACCATTGCGACCATCCTTACC*POSTN*Forward: CAGCCGCATCTGCTCACTATGAC200NM_001030541.1Reverse: CTTCATGTAGCCAGGACAGCACTC*COL14A1*Forward: CCAACTCAGCCACCAACTTCTCC107NM_205334.1Reverse: TCCACTAGGAACACCAGGTCAGC*TGFBI*Forward: ACCACCACGAACAGCATTCAGC87NM_205036.1Reverse: GTTGAGGTCAGAAGCAGCCACAG*ACTN1*Forward: GCGTGGAACAGATTGCTGCTATTG88NM_204127.1Reverse: ATCTTCTGGCACCTGGCATTGAC*NDUFA2*Forward: CATCGAGCAGCACTACGTGACTC159NM_001302137.1Reverse: TTGGCAACTTCATCCACACTGAGG*ADAM19*Forward: GACAGGACAAGCACGGACCATC166NM_001195122.1Reverse: AGGAAGCGGCTCCAGGACATAG*CCR5*Forward: GAGATGCGCTGTGCCGGATTC159NM_001271141.1Reverse: TGCTGGTGAGGATGCCGTAGG

Statistical analysis {#Sec21}
--------------------

The results are expressed as means with their standard error mean (SEM). SPSS 20.0 for Windows (SPSS Inc. Chicago, IL) was applied for One-way ANOVA analysis. Significant difference was considered at *P* \< 0.05.

Supplementary information
=========================

 {#Sec22}

**Additional file 1: Figure S1.** Inflammatory mediator regulation of RTP channels pathway analysis. Differential expressed genes that are involved in the inflammatory mediator regulation of RTP channels \[map 04750\], are highlighted. We thank Kanehisa Laboratories for providing the copyright permission of KEGG pathway maps \[[@CR29]\]. **Additional file 2: Figure S2.** Chemokine signaling pathway analysis. Differential expressed genes that are involved in the chemokine signaling pathway \[map 04062\], are highlighted. We thank Kanehisa Laboratories for providing the copyright permission of KEGG pathway maps \[[@CR29]\]. **Additional file 3: Figure S3.** Calcium signaling pathway analysis. Differential expressed genes that are involved in the calcium signaling pathway \[map 04020\], are highlighted. We thank Kanehisa Laboratories for providing the copyright permission of KEGG pathway maps \[[@CR29]\]. **Additional file 4: Figure S4.** ECM-receptor interaction pathway analysis. Differential expressed genes that are involved in the inflammatory mediator regulation of RTP channels \[map 04512\], are highlighted. We thank Kanehisa Laboratories for providing the copyright permission of KEGG pathway maps \[[@CR29]\]. **Additional file 5: Figure S5.** Adherens junction pathway analysis. Differential expressed genes that are involved in the adherens junction \[map 04520\], are highlighted. We thank Kanehisa Laboratories for providing the copyright permission of KEGG pathway maps \[[@CR29]\]. **Additional file 6: Figure S6.** Focal adhesion pathway analysis. Differential expressed genes that are involved in the focal adhesion \[map 04510\], are highlighted. We thank Kanehisa Laboratories for providing the copyright permission of KEGG pathway maps \[[@CR29]\]. **Additional file 7: Fig. S7.** Oxidative phosphorylation pathway analysis. Differential expressed genes that are involved in the oxidative phosphorylation \[map 00190\], are highlighted. We thank Kanehisa Laboratories for providing the copyright permission of KEGG pathway maps \[[@CR29]\]. **Additional file 8: Figure S8.** Regulation of lipolysis in adipocytes pathway analysis. Differential expressed genes that are involved in the Regulation of lipolysis in adipocytes \[map 04923\], are highlighted. We thank Kanehisa Laboratories for providing the copyright permission of KEGG pathway maps \[[@CR29]\]. **Additional file 9: Figure S9.** Glycolysis/Gluconeogenesis pathway analysis. Differential expressed genes that are involved in the Glycolysis/Gluconeogenesis \[map 00010\], are highlighted. We thank Kanehisa Laboratories for providing the copyright permission of KEGG pathway maps \[[@CR29]\]. **Additional file 10: Figure S10.** Arachidonic acid metabolism pathway analysis. Differential expressed genes that are involved in the arachidonic acid metabolism \[map 00590\], are highlighted. We thank Kanehisa Laboratories for providing the copyright permission of KEGG pathway maps \[[@CR29]\].
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